249 related articles for article (PubMed ID: 19925359)
21. NSAIDs, prostaglandins and the neonatal kidney.
Antonucci R; Fanos V
J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():23-6. PubMed ID: 19701861
[TBL] [Abstract][Full Text] [Related]
22. Pulmonary hypertension following L-lysine ibuprofen therapy in a preterm infant with patent ductus arteriosus.
Bellini C; Campone F; Serra G
CMAJ; 2006 Jun; 174(13):1843-4. PubMed ID: 16785458
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation.
Sperandio M; Beedgen B; Feneberg R; Huppertz C; Brüssau J; Pöschl J; Linderkamp O
Pediatrics; 2005 Dec; 116(6):1361-6. PubMed ID: 16322159
[TBL] [Abstract][Full Text] [Related]
24. Oral ibuprofen for closure of hemodynamically significant PDA in premature neonates.
Hariprasad P; Sundarrajan V; Srimathy G; Suthagar B; Ramadevi BS
Indian Pediatr; 2002 Jan; 39(1):99-100. PubMed ID: 11805364
[No Abstract] [Full Text] [Related]
25. Renal safety of Non Steroidal Anti Inflammatory Drugs (NSAIDs) in the pharmacologic treatment of patent ductus arteriosus.
Fanos V; Marcialis MA; Bassareo PP; Antonucci R; Zaffanello M; Dessì A; Iacovidou N
J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 1():50-2. PubMed ID: 21942591
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of pharmacologic closure of patent ductus arteriosus in small-for-gestational-age extremely preterm infants.
Boghossian NS; Do BT; Bell EF; Dagle JM; Brumbaugh JE; Stoll BJ; Vohr BR; Das A; Shankaran S; Sanchez PJ; Wyckoff MH; Bethany Ball M;
Early Hum Dev; 2017 Oct; 113():10-17. PubMed ID: 28697406
[TBL] [Abstract][Full Text] [Related]
27. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.
Fakhraee SH; Badiee Z; Mojtahedzadeh S; Kazemian M; Kelishadi R
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):399-403. PubMed ID: 17937843
[TBL] [Abstract][Full Text] [Related]
28. High efficacy and minor renal effects of indomethacin treatment during individualized fluid intake in premature infants with patent ductus arteriosus.
Leonhardt A; Strehl R; Barth H; Seyberth HW
Acta Paediatr; 2004 Feb; 93(2):233-40. PubMed ID: 15046280
[TBL] [Abstract][Full Text] [Related]
29. A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus.
Thomas RL; Parker GC; Van Overmeire B; Aranda JV
Eur J Pediatr; 2005 Mar; 164(3):135-40. PubMed ID: 15717178
[TBL] [Abstract][Full Text] [Related]
30. [Renal tolerability of non-steroidal drugs (NSAIDS) in newborn infants].
Fornaro M; Cuzzolin L; Fanos V
Pediatr Med Chir; 2004; 26(6):423-9. PubMed ID: 16363767
[No Abstract] [Full Text] [Related]
31. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
Chotigeat U; Jirapapa K; Layangkool T
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
[TBL] [Abstract][Full Text] [Related]
32. Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus.
Fujii AM; Brown E; Mirochnick M; O'Brien S; Kaufman G
J Perinatol; 2002; 22(7):535-40. PubMed ID: 12368968
[TBL] [Abstract][Full Text] [Related]
33. Renal effects of ibuprofen for the treatment of patent ductus arteriosus in premature infants.
Giniger RP; Buffat C; Millet V; Simeoni U
J Matern Fetal Neonatal Med; 2007 Apr; 20(4):275-83. PubMed ID: 17437233
[TBL] [Abstract][Full Text] [Related]
34. New therapeutic strategies for the treatment of patent ductus arteriosus in preterm infants.
Dani C
J Matern Fetal Neonatal Med; 2011 Nov; 24 Suppl 3():5-6. PubMed ID: 21815877
[TBL] [Abstract][Full Text] [Related]
35. An unreported complication of intravenously administered ibuprofen: gastrointestinal bleeding.
Sarici SU; Dabak O; Erdinc K; Okutan V; Lenk MK
Eur Rev Med Pharmacol Sci; 2012 Mar; 16(3):325-7. PubMed ID: 22530348
[TBL] [Abstract][Full Text] [Related]
36. Ibuprofen and patent ductus arteriosus.
Clyman RI
N Engl J Med; 2000 Sep; 343(10):728-30. PubMed ID: 10974138
[No Abstract] [Full Text] [Related]
37. Pharmacological Closure of Patent Ductus Arteriosus: Selecting the Agent and Route of Administration.
Sivanandan S; Agarwal R
Paediatr Drugs; 2016 Apr; 18(2):123-38. PubMed ID: 26951240
[TBL] [Abstract][Full Text] [Related]
38. Evidence-based use of indomethacin and ibuprofen in the neonatal intensive care unit.
Johnston PG; Gillam-Krakauer M; Fuller MP; Reese J
Clin Perinatol; 2012 Mar; 39(1):111-36. PubMed ID: 22341541
[TBL] [Abstract][Full Text] [Related]
39. A second course of ibuprofen is effective in the closure of a clinically significant PDA in ELBW infants.
Richards J; Johnson A; Fox G; Campbell M
Pediatrics; 2009 Aug; 124(2):e287-93. PubMed ID: 19651568
[TBL] [Abstract][Full Text] [Related]
40. Is there an optimal timing for surgical ligation of patent ductus arteriosus in preterm infants?
Vida VL; Lago P; Salvatori S; Boccuzzo G; Padalino MA; Milanesi O; Speggiorin S; Stellin G
Ann Thorac Surg; 2009 May; 87(5):1509-15; discussion 1515-6. PubMed ID: 19379895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
